Unlocking APS Treatment: Is There a Better Way to Monitor Warfarin Therapy?
Explore the potential of Factor II activity assay (FIIAA) in managing Warfarin therapy for APS patients. Discover how this method could improve monitoring accuracy and reduce thromboembolic risk. Is it time to rethink traditional INR monitoring?